February 26, 2009

FDA cited problems at plant linked to contaminated syringes

The U.S. Food and Drug Administration had cited 'serious underlying problems' at AM2PAT's old plant near Raleigh, N.C. The company and its officials have been charged with falsifying sterility records on pre-filled heparin and saline syringes that sickened more than 100.

Related content